PreprintAll rights reservedbioRxiv
Transglutaminase 3 is a Histone Monoaminylation Writer
Related
- Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors
- Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions
- Immobilization of Microbial Transglutaminase for the Production of Homogeneous Immunotherapeutic Antibody-Drug Conjugates.
- Histone H3K27 methylation states are sequentially catalyzed in cycling cells
- Differential histone tail citrullination by protein arginine deiminases observed via NMR spectroscopy
BibTeX
@misc{ritsema2026transglutaminase,
title = {{Transglutaminase 3 is a Histone Monoaminylation Writer}},
author = {Yvonne Ritsema and Huapeng Li and Xingyu Ma and Anne A. Leaman and Qingfei Zheng},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.20.760504},
url = {https://www.biorxiv.org/content/10.64898/2026.10.20.760504v1},
}
RIS
TY - UNPB
TI - Transglutaminase 3 is a Histone Monoaminylation Writer
AU - Yvonne Ritsema
AU - Huapeng Li
AU - Xingyu Ma
AU - Anne A. Leaman
AU - Qingfei Zheng
PY - 2026
DA - 2026/10/20
PB - bioRxiv
DO - 10.64898/2026.10.20.760504
UR - https://www.biorxiv.org/content/10.64898/2026.10.20.760504v1
SN - 2692-8205
ER -